Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
AMEX
Hana Biosciences (HBX)
Hana Biosciences (HBX) News

Hana Biosciences (HBX)

Hana Biosciences

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:HBX

1

Date	Time	Source	Headline	Symbol	Company
11/04/2006	12:03	Business Wire	Hana Biosciences Obtains NASDAQ National Market Listing Approval; Hana Biosciences Shares to Trade Under Symbol HNAB on the NAS	AMEX:HBX	Hana Biosciences
05/04/2006	12:03	Business Wire	Hana Biosciences to Present at the BIO 2006 Business Forum	AMEX:HBX	Hana Biosciences
31/03/2006	16:03	Business Wire	Hana Biosciences to Present at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceutical Conference	AMEX:HBX	Hana Biosciences
31/03/2006	13:03	Business Wire	Hana Biosciences Initiates Talotrexin Phase II Clinical Trials in Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)	AMEX:HBX	Hana Biosciences
22/03/2006	22:23	Business Wire	Hana Biosciences to Present at the Bear Stearns' Bear Biotech West Coast Confab	AMEX:HBX	Hana Biosciences
16/03/2006	09:03	Business Wire	Hana Biosciences Reports 2005 Results from Operations	AMEX:HBX	Hana Biosciences
09/03/2006	12:02	Business Wire	Hana Biosciences Successfully Completes Pivotal Trials of Zensana(TM), First Proprietary Ondansetron Oral Spray for Chemotherap	AMEX:HBX	Hana Biosciences
06/03/2006	13:30	Business Wire	Hana Biosciences to Present at the Lehman Brothers 9th Annual Global Healthcare Conference	AMEX:HBX	Hana Biosciences
02/03/2006	13:30	Business Wire	Hana Biosciences to Present at BioSquare 2006	AMEX:HBX	Hana Biosciences
28/02/2006	13:30	Business Wire	Hana Biosciences to Present at the Cowen & Co. 26th Annual Health Care Conference	AMEX:HBX	Hana Biosciences
14/02/2006	13:30	Business Wire	Hana Biosciences Announces Issuance of Talotrexin Patent	AMEX:HBX	Hana Biosciences
07/02/2006	13:27	Business Wire	Hana Biosciences to Present at the 8th Annual BIO CEO & Investor Conference	AMEX:HBX	Hana Biosciences
09/01/2006	13:14	Business Wire	Hana Biosciences Announces Positive Results of Initial Registration Trial with Zensana(TM), First Ondansetron Oral Spray for Che	AMEX:HBX	Hana Biosciences
05/01/2006	11:00	Business Wire	Hana Biosciences Announces 2006 Corporate Goals; Key 2005 Achievements Reviewed and 2006 Objectives Announced; Annual Shareholde	AMEX:HBX	Hana Biosciences
17/11/2005	17:07	Business Wire	Hana Biosciences Announces Positive In Vivo Preclinical Results Confirming Pharmacokinetics of Zensana(TM) (Ondansetron Oral Spr	AMEX:HBX	Hana Biosciences
14/11/2005	12:58	Business Wire	Hana Biosciences Announces Positive Interim Results From a Phase I Trial of Talotrexin (PT-523) in Relapsed or Refractory Non-Sm	AMEX:HBX	Hana Biosciences
07/11/2005	13:24	Business Wire	Hana Biosciences to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference	AMEX:HBX	Hana Biosciences
26/10/2005	13:28	Business Wire	Hana Biosciences to Present at 3rd Annual PIPES Conference	AMEX:HBX	Hana Biosciences
25/10/2005	13:30	Business Wire	Hana Biosciences Completes Previously Announced Private Placement	AMEX:HBX	Hana Biosciences
24/10/2005	12:58	Business Wire	Hana Biosciences to Present at Life Sciences Conference Hosted by C.E. Unterberg, Towbin	AMEX:HBX	Hana Biosciences
19/10/2005	20:41	Business Wire	Hana Biosciences Announces $14.7 Million Private Placement	AMEX:HBX	Hana Biosciences
03/10/2005	14:46	Business Wire	Hana Biosciences to Present at BioContact Quebec 2005	AMEX:HBX	Hana Biosciences
22/09/2005	18:45	PR Newswire (US)	American Stock Exchange Lists Common Stock of Hana Biosciences Incorporated	AMEX:HBX

Showing the most relevant articles for your search:AMEX:HBX

1

Surface Transforms

Tower Resources

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions